sglt2 inhibitors vs glp-1 3. Integration of GLP-1RA or SGLT2i in Patients With T2D With or at Risk of atherosclerotic CVD Diabetic Agents, From Metformin to

They also appear to decrease markers of systemic inflammation , which is critical because chronic inflammation fuels atherosclerosis (plaque buildup in arteries)

GLP-1, however, engages the GLP-1R/ERK1/2/HDAC6 axis to modulate downstream transcriptional activity, it lowers intracellular ROS, reduces Akt and ERK1/2 phosphorylation, restores HDAC6 expression, and thereby alleviates endothelial dysfunction and excessive autophagy (Zummo et al., 2017)

Glucagon-like peptide-1 receptor agonist, semaglutide attenuates chronic liver disease-induced skeletal muscle atrophy in diabetic mice

Faktaruta: vanliga skord & begrepp GLP-1, GLP-1 receptoragonist, semaglutid, Ozempic, Wegovy, typ 2-diabetes, obesitas, viktnedgng lkemedel, aptitreglering, dosupptrappning, biverkningar illamende Hur stor viktnedgng kan man f